Prokaryotic Peptide Library Screening via Selectable Markers
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current methods for identifying biologically active random peptides in prokaryotic organisms, such as bacteria, are time-consuming and require specific targets, limiting the efficiency of producing large libraries and screening for biological activity.
Innovation Solution
A method involving the creation of libraries of recombination vectors with test nucleic acid sequences encoding random peptides, flanked by cysteines for stability, and a selectable marker, which are transformed into phenotypically homogenous bacterial cells, allowing for the identification of biologically active peptides by screening for new phenotypes.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Measurement precision
If chemical genomics is used to screen libraries of peptides for biological activity in prokaryotic organisms, then biological activity can be identified, but the process is time-consuming and requires specific targets
Solution Approach 1:
The patent applies preliminary action by incorporating selectable markers into the expression vectors before transformation. This allows for pre-selection of successfully transformed cells, eliminating time-consuming post-transformation screening steps and enabling direct identification of cells expressing candidate peptides.
Solution Approach 2:
The patent uses selectable markers as intermediaries to indirectly identify cells expressing candidate peptides. Instead of directly screening for peptide biological activity in all transformed cells, the selectable marker serves as a mediator to first identify transformed cells, which then can be further screened for peptide activity, significantly reducing the screening pool and time required.
2Adaptability or versatility
If site directed mutagenesis is used to produce peptide libraries, then specific mutations can be designed for desired effects, but specific targets are required and engineering complexity increases
Solution Approach 1:
The patent inverts the traditional site-directed mutagenesis approach by using random peptide sequences instead of pre-designed specific mutations. The expression vectors contain random peptide sequences that are transformed into prokaryotic cells, and the desired biological effects are identified through phenotypic screening rather than being engineered in advance, thereby eliminating the need for specific target knowledge and reducing engineering complexity.
Solution Approach 2:
The patent applies self-service by allowing the random peptide sequences to naturally express and function within the prokaryotic host cells without extensive prior engineering. The cells themselves perform the screening function by exhibiting phenotypic changes when expressing active peptides, eliminating the need for complex external screening apparatus or pre-programmed mutation designs.
3Ease of operation
If eukaryotic-specific methods are used for peptide library screening, then screening can be performed, but the methods are not applicable to prokaryotic systems
Solution Approach 1:
The patent achieves universality by designing an expression vector system that functions across different prokaryotic hosts. The vectors contain essential prokaryotic elements (origin of replication, selectable markers, promoter sequences) that are universally compatible with various prokaryotic organisms, allowing the same screening methodology to be applied to different bacterial and archaeal systems without modification.
Solution Approach 2:
The patent applies parameter changes by adapting the expression vector parameters (promoter strength, ribosome binding sites, terminator sequences) to match prokaryotic transcriptional and translational machinery. These parameter adjustments enable the screening methodology to function effectively in prokaryotic systems rather than eukaryotic systems, making the approach versatile across different organism types.
Data Source
AI summary
The present disclosure provides methods and systems for identifying biologically active random peptides (BARPs) in prokaryotic cells, such as bacterial cells, and libraries of transformed bacterial cells, where each cell/colony expresses a different candidate BARP.